Noom Med Semaglutide Review 2026: Is the App-Based Program Worth It?
An honest noom med semaglutide review for 2026. We evaluate Noom Med's app-based behavioral coaching, GLP-1 medication pricing, clinical evidence, and whether the coaching premium justifies the cost compared to affordable alternatives.
Written by Trimi Medical Team
Medically reviewed by Dr. Amanda Foster, MD
Last updated 2026-04-08
More on GLP-1 Provider Reviews
What Is Noom Med? A Complete Overview
If you are searching for a noom med semaglutide review, you are likely trying to determine whether Noom's prescription weight loss program is worth its monthly cost. Noom Med is the medical arm of Noom, the popular behavioral coaching app, now offering compounded semaglutide alongside its app-based psychological coaching tools. The program pairs a GLP-1 medication prescription with daily lessons, food logging, habit tracking, and personalized coaching rooted in cognitive behavioral therapy. Noom Med positions this combination as a more complete solution than medication-only providers, charging $149 to $209 per month for semaglutide plus a possible additional $32 to $70 per month for the coaching app.
Noom Med, defined: Noom Med is a telehealth weight loss program that bundles compounded semaglutide injections with Noom's behavioral psychology coaching app. It provides GLP-1 medication through licensed providers and layers on daily habit-building content designed to promote sustainable behavior change beyond medication alone.
The central question this review addresses is whether Noom Med's app-based coaching layer justifies a significant price premium over focused medication providers. The clinical evidence is clear on one point: GLP-1 medications are the primary driver of weight loss outcomes. The STEP 1 trial demonstrated that semaglutide 2.4 mg produced 14.9% mean body weight loss over 68 weeks compared to 2.4% with placebo (Wilding et al., New England Journal of Medicine, 2021). That pharmacological effect is identical whether you receive your prescription through Noom Med, Trimi, or any other licensed provider. The coaching app adds behavioral support but does not change how the medication works in your body.
Key Takeaway
Noom Med bundles a coaching app with GLP-1 medication at $149-$209/mo (plus possible $32-$70/mo app fee). The medication itself is the primary driver of weight loss. Trimi offers the same semaglutide at $99/mo and tirzepatide at $125/mo with no app fees, no contracts, and board-certified provider oversight.
What Does Noom Med Include? Breaking Down the Program
Noom Med's value proposition centers on delivering more than a prescription. The program layers several components into a single subscription designed to address both the biological and behavioral aspects of weight management. Understanding exactly what you receive helps determine whether the combined package is worth the premium.
GLP-1 Medication (Semaglutide)
The core of Noom Med is compounded semaglutide, the same active ingredient in brand-name Wegovy. Patients complete an online medical evaluation, and if clinically appropriate, a licensed provider prescribes semaglutide with a standard titration protocol that gradually increases the dose over several months. The medication is shipped directly to the patient. This component is functionally identical to what every other legitimate telehealth GLP-1 provider offers, including more affordable options.
Behavioral Coaching App
Noom's coaching app is what differentiates it from medication-focused providers. The app delivers daily micro-lessons based on cognitive behavioral therapy (CBT) principles, food color-coding and calorie logging tools, daily weigh-in tracking and trend analysis, goal-setting modules and habit-formation exercises, and access to a virtual coach who provides personalized feedback. The app has undergone years of development and has a substantial user base built from Noom's pre-GLP-1 behavioral weight loss program. It is a well-designed product. The relevant question is whether this add-on changes your medication outcomes enough to justify the price difference.
Provider Access
Noom Med includes access to licensed healthcare providers who manage the semaglutide prescription, handle dose titration, and monitor for side effects. Provider interaction is primarily asynchronous through the platform. This level of clinical oversight is standard across telehealth GLP-1 providers and is not unique to Noom Med. For guidance on what to expect from side effects with any semaglutide provider, see our Noom Med side effects guide.
Noom Med Pricing Breakdown: What You Actually Pay
Noom Med's pricing requires careful examination because the total monthly cost may be higher than the headline medication price suggests. The program has a potentially layered cost structure that separates medication from the coaching app in some plans.
Medication Cost
Noom Med charges $149 to $209 per month for compounded semaglutide, depending on dosage tier and plan structure. This covers the prescription, provider oversight, and medication delivery. The price is competitive with other mid-tier telehealth providers but significantly higher than the most affordable options available.
Coaching App Cost
Depending on the plan, the Noom behavioral coaching app may cost an additional $32 to $70 per month on top of the medication fee. Some Noom Med plans bundle the app into the medication price while others charge it separately. This variability makes direct price comparisons challenging and can catch patients off guard when they see multiple charges. If you are evaluating Noom Med, confirm whether your specific plan includes the coaching app or charges it as a separate subscription.
Total Monthly and Annual Cost
At the low end, a Noom Med patient paying $149 per month for medication without the separate app fee spends $1,788 annually. At the high end, a patient paying $209 for medication plus $70 for coaching pays $279 per month, or $3,348 annually. The wide range reflects the complexity of Noom Med's plan structures and the importance of understanding exactly which plan you are signing up for.
Annual Cost Reality Check
Twelve months on semaglutide through Noom Med: $1,788-$3,348 depending on plan. Twelve months through Trimi: $1,188 ($99/mo, all-inclusive). The difference is $600 to $2,160 per year. Over a typical two-year treatment course, that gap becomes $1,200 to $4,320. See our cheapest GLP-1 guide for the full pricing landscape.
Noom Med vs Trimi: Side-by-Side Comparison
The following table compares Noom Med and Trimi across the factors most important to patients choosing a GLP-1 weight loss provider. Both are legitimate telehealth platforms, but their pricing models, program structures, and value propositions differ substantially.
| Feature | Noom Med | Trimi |
|---|---|---|
| Semaglutide cost | $149-$209/mo | $99/mo |
| Tirzepatide cost | Limited availability | $125/mo |
| Coaching app fee | $32-$70/mo (may be separate) | None |
| Total monthly cost (semaglutide) | $149-$279/mo | $99/mo |
| Behavioral coaching | CBT-based app with daily lessons | Clinical guidance included |
| Food logging / habit tracking | Yes (via Noom app) | No |
| Provider consultations | Included (asynchronous) | Included |
| Contract commitment | Varies by plan | None (month-to-month) |
| Medication included in price | Yes (app may be extra) | Yes (all-inclusive) |
| Tirzepatide option | Limited | Available ($125/mo) |
| Estimated 12-month total (semaglutide) | $1,788-$3,348 | $1,188 |
| Best for | Patients who want coaching bundled with medication | Best value for clinically supervised GLP-1 care |
Is Noom's Coaching App Worth the Premium?
This is the critical question in any Noom Med review. The medication itself is available from multiple providers at varying price points. What makes Noom Med different is the coaching app bundled with the prescription. Evaluating whether that app justifies paying $50 to $180 more per month than a focused provider requires examining both the app's value and the clinical evidence on behavioral coaching with GLP-1 therapy.
What the App Does Well
Noom's behavioral coaching app is one of the most polished weight management tools on the market. It has been refined over years of development and millions of users. The daily micro-lessons are grounded in cognitive behavioral therapy and designed to help users understand emotional eating patterns, build positive food relationships, and develop sustainable habits. The food color-coding system simplifies nutritional choices without requiring calorie counting expertise. The virtual coaching provides personalized accountability that some patients find motivating. For patients who will actively engage with these tools daily, the app has genuine utility.
Where the App Falls Short as a Medication Add-On
The limitation is not the app's quality but its relevance to medication-assisted weight loss. Noom's app was originally designed as a standalone behavioral weight loss tool, predating Noom Med's GLP-1 program. Much of the content addresses behavioral drivers of overeating that GLP-1 medications already address pharmacologically. Semaglutide works by activating GLP-1 receptors that suppress appetite, slow gastric emptying, and modulate hunger signaling in the brain. Patients on semaglutide frequently report dramatically reduced food cravings and interest in eating, which is exactly what Noom's behavioral lessons are also trying to achieve through psychological techniques.
This creates a significant overlap. When the medication is already reducing appetite and food noise, the behavioral coaching content designed to manage appetite through mindfulness and cognitive reframing may feel redundant. Patients consistently report that GLP-1 medications accomplish in days what years of behavioral approaches attempted. This does not mean coaching has no value, but it reframes the question: are you paying for a coaching layer that addresses problems the medication is already solving?
The Decoupling Alternative
An important consideration that Noom Med's marketing does not emphasize: you do not need to get your coaching and your medication from the same provider. The Noom coaching app is available as a standalone subscription for approximately $32 to $70 per month. You can subscribe to the app independently while getting your semaglutide from a more affordable provider. A standalone Noom app ($32-$70/mo) paired with Trimi semaglutide ($99/mo) costs $131 to $169 per month total. This is often less than Noom Med's bundled pricing while giving you the identical coaching content and the identical medication with potentially better clinical value.
The Decoupling Strategy
Separate your medication from your coaching tools. Get semaglutide from Trimi at $99/mo and subscribe to Noom's app (or any coaching tool) independently. You get the same medication, the same coaching, more flexibility, and often a lower total monthly cost than Noom Med's bundled program.
Clinical Evidence: What the Research Shows
Any credible review of Noom Med's semaglutide program must evaluate the clinical evidence supporting both the medication and the coaching component. The research strongly supports GLP-1 medications for weight loss and provides nuanced guidance on the incremental value of behavioral therapy alongside medication.
Semaglutide Efficacy (STEP 1 Trial)
The landmark STEP 1 trial enrolled 1,961 adults with obesity or overweight and randomized them to receive semaglutide 2.4 mg weekly or placebo. Participants receiving semaglutide achieved a mean body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo. Additionally, 86.4% of semaglutide participants achieved at least 5% body weight loss, and 69.1% achieved at least 10% loss. Participants also experienced meaningful improvements in cardiometabolic markers including waist circumference, blood pressure, and glycated hemoglobin (Wilding et al., New England Journal of Medicine, 2021). For a 220-pound individual, this translates to approximately 33 pounds of weight loss over the treatment period.
Tirzepatide Efficacy (SURMOUNT-1 Trial)
While Noom Med primarily offers semaglutide, the comparative context matters. The SURMOUNT-1 trial enrolled 2,539 adults and demonstrated that tirzepatide at the highest dose (15 mg weekly) achieved 22.5% mean body weight loss over 72 weeks, with 63% of participants losing at least 20% of their body weight (Jastreboff et al., New England Journal of Medicine, 2022). Tirzepatide's dual GIP/GLP-1 receptor mechanism produces superior weight loss outcomes compared to semaglutide alone. Noom Med's limited tirzepatide availability is a notable gap in their offering. Trimi offers tirzepatide at $125 per month for patients who want access to the most effective GLP-1-class therapy available.
Behavioral Therapy Plus Medication (Wadden et al.)
The study most directly relevant to evaluating Noom Med's coaching premium comes from Wadden et al., who examined whether adding intensive behavioral therapy to semaglutide improves outcomes compared to medication with standard care alone. The results showed that structured behavioral intervention produced modestly greater weight loss when combined with semaglutide. However, the incremental benefit of behavioral therapy was substantially smaller than the difference between semaglutide and placebo (JAMA, 2021). In practical terms, the medication alone accounts for the vast majority of weight loss, and behavioral coaching adds a marginal improvement. This finding directly challenges the core justification for Noom Med's pricing premium.
Long-Term Maintenance Considerations
The strongest argument in favor of Noom Med's behavioral approach involves long-term weight maintenance. The STEP 1 extension data showed that participants who discontinued semaglutide regained a significant portion of lost weight within a year (Wilding et al., Diabetes, Obesity and Metabolism, 2022). This underscores the importance of sustainable behavioral changes that persist after medication. However, this benefit is not exclusive to Noom Med's app. Patients can develop sustainable habits through many channels including independent coaching apps, dietitian consultations, support groups, or self-directed behavioral work. The question is not whether behavioral support has value but whether it must be bundled with and purchased from your medication provider.
Evidence Summary
Semaglutide: 14.9% body weight loss over 68 weeks (STEP 1, Wilding et al., 2021). Tirzepatide: up to 22.5% body weight loss over 72 weeks (SURMOUNT-1, Jastreboff et al., 2022). Behavioral therapy adds modest incremental benefit on top of medication (Wadden et al., JAMA, 2021). The medication is the primary determinant of outcomes regardless of provider. Learn more on our semaglutide and tirzepatide treatment pages.
Noom Med Pros and Cons
A balanced Noom Med review requires honestly assessing both the program's genuine strengths and its limitations. The platform has real advantages for certain patient profiles and real disadvantages that affect its value proposition for others.
Noom Med Strengths
Well-designed behavioral coaching app with years of development and millions of users
Daily CBT-based lessons that promote understanding of eating behaviors and emotional triggers
Food color-coding system simplifies nutritional choices without complex calorie counting
Integrated experience combining medication management and behavioral tools in one platform
Virtual coaching provides personalized accountability for patients who engage consistently
Licensed provider oversight for medication management and dose titration
Noom Med Limitations
Total monthly cost of $149-$279 is 50% to 180% more than focused medication providers like Trimi
Coaching app fee may be charged separately from medication, creating confusing two-tier pricing
Behavioral coaching does not change the pharmacological efficacy of semaglutide
Much of the app's behavioral content overlaps with what GLP-1 medication already accomplishes biologically
Limited tirzepatide availability restricts access to the most effective GLP-1-class medication
Cancellation terms vary by plan, and some subscriptions auto-renew with specific cancellation windows
The same coaching app can be purchased independently for less than the bundled Noom Med price
No published clinical data comparing Noom Med's specific program to standard GLP-1 management
The Bottom Line: Is Noom Med Worth It in 2026?
Noom Med is a legitimate telehealth weight loss program built on a well-designed behavioral coaching platform. The app is polished, the providers are licensed, and the semaglutide is real. For the right patient, Noom Med delivers a comprehensive experience that combines medication with structured behavioral support.
However, the value proposition weakens substantially when you consider the clinical evidence. GLP-1 medication drives the vast majority of weight loss outcomes, and that medication is pharmacologically identical regardless of provider. Behavioral coaching adds modest incremental benefit but does not transform the medication's efficacy. The $600 to $2,160 annual premium Noom Med charges over providers like Trimi funds the coaching experience, not enhanced medication.
Noom Med makes sense if you will actively use the coaching app every day
Patients who engage daily with the behavioral lessons, food logging, and coaching messages get the most value from Noom Med's bundled approach. The app is genuinely well-designed and can support meaningful habit formation. However, if you subscribe and skip the daily content after the first few weeks, as many app users do, you are paying a premium for features you are not using. Be honest with yourself about how consistently you use wellness apps before committing.
Trimi makes sense if you want effective medication at the best price
For patients primarily seeking clinically supervised GLP-1 therapy, Trimi offers semaglutide at $99 per month and tirzepatide at $125 per month with board-certified provider oversight, no contracts, and no supplementary fees. The medication works identically to what Noom Med prescribes. Over twelve months, you save $600 to $2,160 compared to Noom Med. Over a typical two-year treatment course, savings reach $1,200 to $4,320.
The smartest approach may be to separate medication from coaching
Get your semaglutide from a focused, affordable provider like Trimi and subscribe to Noom's coaching app (or any behavioral tool) independently. This decoupled strategy often costs less than Noom Med's bundled pricing, gives you the same tools and medication, and provides the flexibility to change either component independently. If you want to cancel coaching but continue medication, or vice versa, you are not locked into a single platform.
GLP-1 therapy is a long-term treatment. Most patients require twelve months or longer to achieve and sustain meaningful results. The financial difference between providers compounds over time: choosing the most affordable clinically sound option means you can stay on treatment long enough for the medication to deliver its full benefit. If you are currently on Noom Med and considering a switch, see our step-by-step guide to canceling Noom Med and switching providers. For a broader comparison of how Noom Med stacks up against other platforms, read our Noom vs Hims comparison. Ready to explore a more affordable path? Start with Trimi's free assessment to see if you qualify.
Frequently Asked Questions
What is Noom Med and how does it work?
Noom Med is the prescription arm of Noom's weight loss platform. It pairs compounded semaglutide with Noom's app-based behavioral coaching program built on cognitive behavioral therapy principles. Patients receive GLP-1 medication through a telehealth consultation, and the Noom app delivers daily lessons, food logging tools, habit tracking, and personalized coaching messages. The medication costs $149 to $209 per month, and the coaching app may cost an additional $32 to $70 per month depending on plan structure.
How much does Noom Med semaglutide cost per month?
Noom Med charges $149 to $209 per month for compounded semaglutide depending on the dosage tier. The Noom behavioral coaching app may cost an additional $32 to $70 per month, bringing the total potential cost to $181 to $279 per month. By comparison, Trimi offers semaglutide at $99 per month with no separate app fees or contracts.
Does Noom Med's coaching app actually improve GLP-1 weight loss results?
Noom's app is based on cognitive behavioral therapy principles and can help patients build sustainable habits. However, clinical evidence shows that the medication is the dominant driver of weight loss outcomes. Wadden et al. found that adding intensive behavioral therapy to semaglutide produced only modestly greater weight loss than medication with standard care (JAMA, 2021). The coaching may support long-term habit formation but does not change how effectively the GLP-1 medication works.
Can I use Noom's coaching app without Noom Med?
Yes. You can subscribe to Noom's behavioral coaching app independently and get your semaglutide prescription from a separate, more affordable provider like Trimi. This decoupled approach often costs less than Noom Med's bundled program while giving you access to the same coaching tools and the same medication.
Is Noom Med worth it compared to cheaper semaglutide providers?
Noom Med is worth considering for patients who will actively and consistently engage with the behavioral coaching app and find it valuable for building long-term habits. For patients primarily seeking effective, supervised semaglutide therapy, the coaching premium is difficult to justify. Trimi delivers the same medication with board-certified provider oversight at $99 per month, saving $600 to $2,100 or more annually compared to Noom Med.
Does Noom Med offer tirzepatide?
As of early 2026, Noom Med's GLP-1 program primarily focuses on semaglutide. Tirzepatide availability through Noom Med remains limited. Patients interested in tirzepatide, which showed up to 22.5% body weight loss in the SURMOUNT-1 trial, can access it through providers like Trimi at $125 per month.
How do I cancel Noom Med if I want to switch providers?
Noom Med cancellation terms vary by plan, and some subscriptions auto-renew or have specific cancellation windows. Review your plan terms and contact Noom's support team directly. You can transition to a more affordable provider like Trimi without a gap in treatment. See our detailed guide on canceling Noom Med and switching providers for step-by-step instructions.
Sources & References
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine, 2021;384(11):989-1002.
- Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine, 2022;387(4):327-340.
- Wadden TA, et al. "Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults with Overweight or Obesity." JAMA, 2021;325(14):1403-1413.
- Wilding JPH, et al. "Weight regain and cardiometabolic effects after withdrawal of semaglutide." Diabetes, Obesity and Metabolism, 2022;24(8):1553-1564.
- Noom, Inc. Noom Med official pricing and program information. 2026.
- Wegovy (semaglutide) prescribing information. U.S. Food and Drug Administration.
- Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Pricing and program details are approximate, based on publicly available information as of April 2026, and subject to change. Verify current pricing directly with Noom Med. This article was prepared by the Trimi Medical Team and reviewed by Dr. Amanda Foster, MD. Trimi is a competing provider; this review is presented fairly but readers should independently verify all claims.